Pioneering, proven pain treatment for knee OA
Arthrosamid® — The first and only synovial scaffold administered via a single injectable for long-lasting pain relief.
![Arthrosamid®- Pioneering, proven pain treatment for knee OA](/_next/image?url=https%3A%2F%2Farthrosamid.ams3.cdn.digitaloceanspaces.com%2Fnew-uploads%2FLifestyle%2F_1800xAUTO_crop_center-center_none%2Fcouple-enjoying-a-day-outdoors.jpeg&w=3840&q=75)
About 528 million
people worldwide were living with osteoarthritis in 2019; an increase of 113% since 1990.
The Problem
Despite osteoarthritis (OA) being the most common type of arthritis and the fastest-growing cause of disability worldwide, the treatment area has seen minimal progression in the last 20 years. With so little known about exactly what causes knee OA, a permanent cure has yet to be discovered.
Redefining treatment for knee OA, without surgery
Arthrosamid® is a non-biodegradable 2.5 iPAAG injectable implant that delivers long-lasting pain relief — improving the quality of life for patients with knee OA.
![Arthrosamid® ultrasound guided injections](/_next/image?url=https%3A%2F%2Farthrosamid.ams3.cdn.digitaloceanspaces.com%2Fnew-uploads%2FKnee-Pain%2F_1000xAUTO_crop_center-center_none%2Fclinician-conducts-ultrasound-examination-on-patients-knee.jpeg&w=3840&q=75)
Pioneering
Arthrosamid® is a first-in-class synovial scaffold delivered as a single, minimally invasive out-patient procedure performed under local anaesthesia, with ultrasound guidance.
Proven
Researched for more than two decades, Arthrosamid® has been proven to maintain a statistically significant reduction in pain in patients with knee OA 3 years after treatment.
Pain Relief Treatment
A single, minimally invasive, long-lasting knee OA treatment, Arthrosamid® has demonstrated an improvement in quality of life with patients in clinical trials reporting a reduction in pain by Week 4 — and lasting over 3 years.
![Arthrosamid syringes](/_next/image?url=https%3A%2F%2Farthrosamid.ams3.cdn.digitaloceanspaces.com%2Fnew-uploads%2F_1000xAUTO_crop_center-center_none%2FOSP-ARTHROSAMID_0454-copy.jpg&w=3840&q=75)
10,000+ patients
Arthrosamid® has treated more than 10,000 patients and is available in over 200 clinics across Europe.
Simple one-step outpatient procedure
Relieve pain and improve the function of the knee affected by knee OA, with a simple, one-step outpatient procedure.
Our Results
In all our studies , Arthrosamid® exceeds the MCID of 9 points and improvement is maintained up to 3 years after a single injection.
WOMAC pain subscale change from baseline across studies
344 million people living with osteoarthritis experience severity levels (moderate or severe) that could benefit from rehabilitation.
![Arthrosamid®Rehab Programme](/_next/image?url=https%3A%2F%2Farthrosamid.ams3.cdn.digitaloceanspaces.com%2Fnew-uploads%2FLifestyle%2F_1000xAUTO_crop_center-center_none%2FP1600747.00_00_17_06.Still003.png&w=3840&q=75)
Patient Rehabilitation Programme
We are delighted to introduce our patient rehabilitation programme. Click on the link below to see the videos.